Carcinoid Tumors and Medical Advancements

Carcinoid tumors, a subset of appendicular tumors, originate from neuroendocrine cells and can develop in various organs, including the lungs, intestines, and stomach. These tumors secrete hormones like serotonin, leading to carcinoid syndrome.

At A Glance

Treatment Options

Surgical Removal: The primary and most effective treatment for localized tumors.
Embolization Therapy: Used for metastatic tumors in the liver, this method helps in blocking the tumor’s blood supply.
Targeted Medications: Somatostatin analogs and chemotherapy can aid in managing tumor progression.

Prognosis: Patients diagnosed with early-stage carcinoid tumors often have a favorable outlook, with survival rates extending up to 10-15 years post-treatment.

Products
Patents
K
Employees
Countries
Our Company

Fast Growing Pharma
Company

Mattis tristique tincidunt scelerisque neque felis non sed sed dignissim sit ornare fermentum velit amet mauris eget dui scelerisque augue cum tellus aliquet donec leo, euismod id mattis eu, tortor sit eget commodo egestas tincidunt tortor justo, porta pulvinar at.

Odio vel in nunc aenean dignissim dignissim mattis elementum id sed senectus laoreet blandit faucibus vitae quam aliquam nibh lacus, rhoncus massa placerat urna.
Olivia Michelle Founder, CEO of evermed
Therapeutic Areas of Focus

Neurology and Oncology

Odio vel in nunc aenean dignissim dignissim mattis elementum id sed senectus laoreet blandit faucibus vitae quam aliquam nibh lacus, rhoncus massa placerat urna.

Mattis tristique tincidunt scelerisque neque felis non sed sed dignissim sit ornare fermentum velit amet mauris eget dui scelerisque augue cum tellus aliquet donec leo, euismod id mattis eu, tortor sit eget commodo egestas tincidunt tortor justo, porta pulvinar at.

Awards & Recognition

2000
2005
2008
2011
2005
2000
2011
2008
PATNERSHIP

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin

Contact Us

Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.